Published in Diabetologia on July 30, 2010
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol (2013) 1.20
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care (2011) 1.08
Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care (2011) 1.03
Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol (2015) 1.00
More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care (2012) 1.00
Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care (2013) 0.98
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2014) 0.92
An update on coronary artery disease and chronic kidney disease. Int J Nephrol (2014) 0.89
Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care (2013) 0.88
Clinical impact of albuminuria in diabetic nephropathy. Clin Exp Nephrol (2011) 0.87
Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria. Int J Endocrinol (2013) 0.85
Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol (2013) 0.85
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol (2013) 0.84
Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study. Cardiovasc Diabetol (2013) 0.82
Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes. Endocrinol Metab (Seoul) (2016) 0.82
Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease. BMC Nephrol (2013) 0.81
Do fibrates truly preserve kidney function? Nat Rev Endocrinol (2011) 0.81
Trends in estimated kidney function: the FINRISK surveys. Eur J Epidemiol (2012) 0.81
Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes. Biomed Res Int (2013) 0.80
Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One (2015) 0.80
High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open (2015) 0.80
The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community. Clin Kidney J (2012) 0.79
Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria. Medicine (Baltimore) (2016) 0.78
Chronic kidney disease: Albuminuria or CKD stage as best marker of CVD in diabetes? Nat Rev Nephrol (2012) 0.78
Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol (2017) 0.78
Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women. J Res Med Sci (2012) 0.77
Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes? Open Cardiovasc Med J (2012) 0.77
Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease. PLoS One (2015) 0.77
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care (2016) 0.76
Diabetes: Assessing renal risk in patients with type 2 diabetes. Nat Rev Nephrol (2013) 0.76
Decreased eGFR as a Risk Factor for Heart Failure in 13 781 Individuals With Type 1 Diabetes. J Diabetes Sci Technol (2015) 0.75
Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes. Hypertens Res (2016) 0.75
Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy? Endocrinol Metab (Seoul) (2016) 0.75
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
High-performance lithium-ion anodes using a hierarchical bottom-up approach. Nat Mater (2010) 3.25
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res Hum Retroviruses (1988) 2.99
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab (2005) 2.37
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation (1995) 2.36
Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation (1995) 2.24
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Lack of independent relationships between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Hypertens (1996) 1.95
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart (2007) 1.91
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia (2010) 1.88
Standardization of IVGTT to predict IDDM. Diabetes Care (1992) 1.83
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]. Cardiovasc Diabetol (2005) 1.71
A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia (2005) 1.71
Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci U S A (2000) 1.67
Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet (2000) 1.66
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells. Int J Cancer (1980) 1.61
Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2013) 1.61
Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc (1997) 1.59
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet (2000) 1.56
Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome. Gastroenterology (1986) 1.52
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation (2000) 1.51
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother (2004) 1.49
Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin Endocrinol (Oxf) (2005) 1.49
The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study. Intern Med J (2006) 1.48
Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest (1996) 1.48
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med (1982) 1.45
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.42
Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns (2001) 1.42
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis. Curr Med Res Opin (2012) 1.39
Paracetamol-associated coma, metabolic acidosis, renal and hepatic failure. Intensive Care Med (1988) 1.39
Dust mite allergens in the office environment. Am Ind Hyg Assoc J (1995) 1.39
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem (2001) 1.30
Lack of association of recreational cocaine and alcohol use with left ventricular mass in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) study. J Am Coll Cardiol (1995) 1.29
The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis (2001) 1.29
Ribosomes in thiostrepton-resistant mutants of Bacillus megaterium lacking a single 50 S subunit protein. J Mol Biol (1979) 1.29
Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia (2006) 1.28
The influence of fish cage aquaculture on pelagic carbon flow and water chemistry in tidally dominated mangrove estuaries of peninsular Malaysia. Mar Environ Res (2003) 1.26
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes (1977) 1.23
An assessment of US and Canadian smoking reduction objectives for the year 2000. Am J Public Health (1998) 1.22
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. Can J Gastroenterol (2007) 1.20
The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol (1996) 1.20
University of Alberta norms of relative meaning frequency for 566 homographs. Mem Cognit (1994) 1.20
Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia (2009) 1.19
The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J (1996) 1.19
Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ (1994) 1.18
Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer. Lung Cancer (1997) 1.17
A chemical method for introducing haptens onto DNA probes. Anal Biochem (1988) 1.17
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J Cell Sci (1998) 1.16
The impact of nursing grade on the quality and outcome of nursing care. Health Econ (1995) 1.16
Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia (2007) 1.16
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta (1971) 1.14
PCR amplification of alleles at the DIS80 locus: comparison of a Finnish and a North American Caucasian population sample, and forensic casework evaluation. Am J Hum Genet (1992) 1.13
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res (1989) 1.13
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia (2007) 1.12
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice. Qual Saf Health Care (2006) 1.11